VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESGO 2021 | Immune checkpoint inhibitors in ovarian cancer

Eric Pujade-Lauraine, MD, PhD, Hôpital Hôtel-Dieu, Paris, France, outlines the use of immunotherapy in ovarian cancer, the PD1/PD-L1 pathway, as well as novel targets for therapy. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter